Janux Therapeutics, Inc. (JANX)
13.72
-0.40
(-2.83%)
USD |
NASDAQ |
Jan 15, 16:00
13.72
0.00 (0.00%)
After-Hours: 17:16
Janux Therapeutics SG&A Expense (TTM): 39.13M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 10.39B |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| MannKind Corp. | 195.42M |
| Madrigal Pharmaceuticals, Inc. | 715.08M |
| Editas Medicine, Inc. | 54.90M |